GlassScriptPhysician profile
Anna Gasparyan
NPI 1598055923
$15,722.56
in general payments reported to CMS, 2019-2025
27 companies · $5,437 in 2025
The $5,437 reported for 2025 was more than what 85% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.64 · 2020: $144 · 2021: $399 · 2022: $411 · 2023: $3,680 · 2024: $5,556 · 2025: $5,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $13K · Food and Beverage: $1,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $12,760.00 |
| Food and Beverage | $1,913.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $13,118.83 | 2023-2025 | Venacure 1470 Pro, Bioflo, Venacure 1470 Pro |
| Novo Nordisk INC | $237.09 | 2024-2025 | Wegovy |
| Smith+Nephew, INC. | $204.16 | 2019-2025 | Collagenase Santyl, Pico 14 |
| Bard Peripheral Vascular, INC. | $201.14 | 2021-2024 | Venclose Maven Catheter |
| Inari Medical, INC. | $197.32 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $177.81 | 2021-2024 | Proclaim |
| Stryker Corporation | $145.52 | 2025 | Artix Mt |
| Intuitive Surgical, INC. | $144.60 | 2022 | |
| W. L. Gore & Associates, INC. | $130.63 | 2022 | |
| Artivion, INC. | $125.89 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $123.48 | 2025 | |
| Amgen INC. | $123.13 | 2024 | Krystexxa |
| Mimedx Group, INC. | $120.60 | 2024 | |
| Medtronic Vascular, INC. | $100.42 | 2020 | |
| Integra Lifesciences Corporation | $99.14 | 2023 | Durasorb Monofilament Mesh |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $75.17 | 2023-2025 | Endurant Iis, Pivox Oblique Lateral Spinal System |
| Tactile Systems Technology INC | $74.83 | 2021-2024 | Entre Plus, Flexitouch Plus |
| Organogenesis INC. | $55.23 | 2021 | |
| Boston Scientific Corporation | $45.00 | 2023-2024 | Varithena Administration Pack |
| Venclose INC. | $43.80 | 2020 | |
| Endologix LLC | $40.94 | 2024 | Alto Abdominal Stent Graft System |
| Acell, INC. | $27.18 | 2019 | |
| Livanova USA, INC. | $26.18 | 2022 | |
| Janssen Pharmaceuticals, INC | $26.16 | 2019 | |
| Allergan, INC. | $23.45 | 2019 | |
| Solventum Corporation | $20.50 | 2025 | Activ.A.C. |
| Convatec INC. | $14.36 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Gasparyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.